Works matching IS 00070963 AND DT 2024 AND VI 190 AND IP 2

Results: 47
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 2, p. 216, doi. 10.1093/bjd/ljad397
    By:
    • Fertitta, Laura;
    • Bergqvist, Christina;
    • Sarin, Kavita Y;
    • Plotkin, Scott R;
    • Moertel, Christopher;
    • Petersen, Andrea K;
    • Cannon, Ashley;
    • Berman, Yemima;
    • Pichard, Dominique C;
    • Röhl, Class;
    • Lessing, Andres;
    • Brizion, Bernadette;
    • Peiffer, Bastien;
    • Ravaud, Philippe;
    • Tran, Viet-Thi;
    • Armand, Marie-Laure;
    • Moryousef, Sabine;
    • Ferkal, Salah;
    • Jannic, Arnaud;
    • Ezzedine, Khaled
    Publication type:
    Article
    29
    30
    31
    32

    Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 2, p. 226, doi. 10.1093/bjd/ljad390
    By:
    • Pacot, Laurence;
    • Sabbagh, Audrey;
    • Sohier, Pierre;
    • Hadjadj, Djihad;
    • Ye, Manuela;
    • Boland-Auge, Anne;
    • Bacq-Daian, Delphine;
    • Laurendeau, Ingrid;
    • Briand-Suleau, Audrey;
    • Deleuze, Jean-François;
    • Margueron, Raphaël;
    • Vidaud, Michel;
    • Ferkal, Salah;
    • Parfait, Béatrice;
    • Vidaud, Dominique;
    • Network, the NF-France;
    • Pasmant, Eric;
    • Wolkenstein, Pierre
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 2, p. 258, doi. 10.1093/bjd/ljad369
    By:
    • Chebani, Réda;
    • Lombart, Florian;
    • Chaby, Guillaume;
    • Dadban, Ali;
    • Debarbieux, Sébastien;
    • Viguier, Manuelle-Anne;
    • Ingen-Housz-Oro, Saskia;
    • Pham-Ledard, Anne;
    • Bedane, Christophe R;
    • Picard-Dahan, Catherine;
    • Berthin, Clémence;
    • Dereure, Olivier;
    • Konstantinou, Maria-Polina;
    • Castel, Marion;
    • Jouen, Fabienne;
    • Joly, Pascal;
    • Seta, Vannina;
    • Duvert-Lehembre, Sophie;
    • Roux, Christelle Le;
    • Quereux, Gaëlle
    Publication type:
    Article
    39
    40
    41
    42

    British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 2, p. 270, doi. 10.1093/bjd/ljad347
    By:
    • Smith, Catherine H;
    • Yiu, Zenas Z N;
    • Bale, Tracy;
    • Burden, A David;
    • Coates, Laura C;
    • Eckert, Elizabeth;
    • Longley, Nicky;
    • Mahil, Satveer K;
    • McGuire, Arlene;
    • Murphy, Ruth;
    • Nelson-Piercy, Catherine;
    • Owen, Caroline M;
    • Parslew, Richard;
    • Woolf, Richard T;
    • Kiaee, Zahra Mansour;
    • Constantin, Alina M;
    • Ezejimofor, Martinsixtus C;
    • Exton, Lesley S;
    • Mustapa, M Firouz Mohd
    Publication type:
    Article
    43
    44
    45

    Failure of scabies treatment: a systematic review and meta-analysis.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 2, p. 163, doi. 10.1093/bjd/ljad308
    By:
    • Mbuagbaw, Lawrence;
    • Sadeghirad, Behnam;
    • Morgan, Rebecca L;
    • Mertz, Dominik;
    • Motaghi, Shahrzad;
    • Ghadimi, Maryam;
    • Babatunde, Ifeoluwa;
    • Zani, Babalwa;
    • Pasumarthi, Tejanth;
    • Derby, McKenzie;
    • Kothapudi, Venkata N;
    • Palmer, Nicole R;
    • Aebischer, Anton;
    • Harder, Thomas;
    • Reichert, Felix
    Publication type:
    Article
    46
    47